Molly S. McGlaughlin
Nessuna posizione attualmente
Profilo
Molly S.
McGlaughlin held several positions in sales, business development, and strategy at various biotech and pharmaceutical companies, including Avantor Performance Materials LLC, BioVectra, Inc., Patheon, Inc., Cytovance Biologics, Inc., Natrix Separations, Inc., Selexis SA, Nitto Denko Avecia, Inc., EirGenix, Inc., Vigene Biosciences, Inc., and Tenshi Healthcare Pte Ltd.
She also has an undergraduate degree from Norwich University and graduate degrees from the U.S.
Army War College, Capella University LLC, and the University of Massachusetts Boston.
Precedenti posizioni note di Molly S. McGlaughlin
Società | Posizione | Fine |
---|---|---|
Tenshi Healthcare Pte Ltd.
Tenshi Healthcare Pte Ltd. Financial ConglomeratesFinance Tenshi Healthcare Pte Ltd. is the Singaporean parent company of Biolexis Therapeutics, a clinical-stage biopharmaceutical company that develops small molecules targeting various diseases, including cancers, immune-mediated, neurodegenerative, auto-immune, metabolic, and inflammatory diseases. The private company is based in Singapore, Singapore. Biolexis uses a proprietary molecular AI-enabled drug discovery process to rapidly discover and develop novel clinical candidates. The company is also focused on building and in-licensing a portfolio of advanced biosimilars, peptides, and vaccines with a high focus on quality, affordability, and accessibility. Biolexis has a proprietary platform technology to develop and commercialize recombinant insulin and insulin analogs with high purity and consistent quality. | Presidente | 30/11/2021 |
Vigene Biosciences, Inc.
Vigene Biosciences, Inc. BiotechnologyHealth Technology Vigene Biosciences, Inc. provides viral vector-based gene delivery services and products for research and clinical applications. Its products include AAV products, AAV controls, AAV biosensors, Adenovirus miRNAs, Adenovirus Zika ORFs, Lentivirus controls, plasmid ORFs and plasmid shRNAs. The company was founded by Zairen Sun in 2012 and is headquartered in Rockville, MD. | Direttore operativo | 30/11/2021 |
BioVectra, Inc.
BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Responsabile della Conformità | 31/08/2018 |
EIRGENIX INC. | Presidente | 30/06/2016 |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Responsabile della Conformità | - |
Formazione di Molly S. McGlaughlin
Norwich University | Undergraduate Degree |
U.S. Army War College | Graduate Degree |
Capella University LLC | Graduate Degree |
University of Massachusetts Boston | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
EIRGENIX INC. | Health Technology |
Aziende private | 9 |
---|---|
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Avantor Performance Materials LLC
Avantor Performance Materials LLC Chemicals: Major DiversifiedProcess Industries Avantor Performance Materials LLC manufactures and markets chemicals for the biopharmaceutical industry. The firm’s products include acids, amino acids, denaturants, excipients, molecular biology products, salts, stains and dynes, sugars and biological buffers and reagents. The company was founded in 1904 and is headquartered in Center Valley, PA. | Process Industries |
NATRIX Separations, Inc.
NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Health Technology |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
BioVectra, Inc.
BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Health Technology |
Nitto Denko Avecia, Inc.
Nitto Denko Avecia, Inc. Miscellaneous Commercial ServicesCommercial Services Nitto Denko Avecia, Inc. develops and manufactures therapeutic nucleic acid. Its services include custom DNA and RNA synthesis, specialized synthesis services, and purification and downstream processing. The company is headquartered in Milford, MA. | Commercial Services |
Vigene Biosciences, Inc.
Vigene Biosciences, Inc. BiotechnologyHealth Technology Vigene Biosciences, Inc. provides viral vector-based gene delivery services and products for research and clinical applications. Its products include AAV products, AAV controls, AAV biosensors, Adenovirus miRNAs, Adenovirus Zika ORFs, Lentivirus controls, plasmid ORFs and plasmid shRNAs. The company was founded by Zairen Sun in 2012 and is headquartered in Rockville, MD. | Health Technology |
Tenshi Healthcare Pte Ltd.
Tenshi Healthcare Pte Ltd. Financial ConglomeratesFinance Tenshi Healthcare Pte Ltd. is the Singaporean parent company of Biolexis Therapeutics, a clinical-stage biopharmaceutical company that develops small molecules targeting various diseases, including cancers, immune-mediated, neurodegenerative, auto-immune, metabolic, and inflammatory diseases. The private company is based in Singapore, Singapore. Biolexis uses a proprietary molecular AI-enabled drug discovery process to rapidly discover and develop novel clinical candidates. The company is also focused on building and in-licensing a portfolio of advanced biosimilars, peptides, and vaccines with a high focus on quality, affordability, and accessibility. Biolexis has a proprietary platform technology to develop and commercialize recombinant insulin and insulin analogs with high purity and consistent quality. | Finance |
- Borsa valori
- Insiders
- Molly S. McGlaughlin